Gara Jalqabaatti › Flu
Qorannoo klinikaalii Flu Ameerikaa Keessatti hirmaatuu
Qorannoo 39 Flu f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Atlanta, GAQorannoo 9
- Washington, DCQorannoo 7
- Chicago, ILQorannoo 5
- Philadelphia, PAQorannoo 5
- Charlottesville, VAQorannoo 5
- Houston, TXQorannoo 4
- Baltimore, MDQorannoo 4
- St. Louis, MOQorannoo 4
- Hialeah, FLQorannoo 4
- Seattle, WAQorannoo 4
- Durham, NCQorannoo 4
- Salt Lake City, UTQorannoo 4
- Miami, FLQorannoo 3
- San Diego, CAQorannoo 3
- Pittsburgh, PAQorannoo 3
- Kansas City, MOQorannoo 3
- Winston-Salem, NCQorannoo 3
- Columbus, OHQorannoo 3
- Portland, ORQorannoo 3
- Torrance, CAQorannoo 3
- Rochester, NYQorannoo 3
Naannoon
- AlabamaQorannoo 5
- ArizonaQorannoo 3
- ArkansasQorannoo 3
- CaliforniaQorannoo 10
- ConnecticutQorannoo 3
- FloridaQorannoo 7
- GeorgiaQorannoo 10
- IdahoQorannoo 3
- IllinoisQorannoo 7
- KansasQorannoo 3
- LouisianaQorannoo 4
- MarylandQorannoo 9
- MichiganQorannoo 3
- MissouriQorannoo 6
- New YorkQorannoo 5
- North CarolinaQorannoo 5
- OhioQorannoo 5
- OregonQorannoo 3
- PennsylvaniaQorannoo 9
- South CarolinaQorannoo 3
- TennesseeQorannoo 4
- TexasQorannoo 8
- UtahQorannoo 4
- VirginiaQorannoo 5
- WashingtonQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
BPL-1357 Against H1N1 Influenza Virus Challenge
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07215858pH1N1 Blinded Challenge Study
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 55 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07110532Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05624450Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06160128A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Namoota walitti qabaa jiraSadarkaa 3
3 Weeks – 11 Years · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06094010High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 3 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT05947071Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07786467Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT01386424A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07805707Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07779408Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06863142Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT04772170Dime La VerDAD: Verify, Debunk, and Disseminate
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06417762Respiratory Virus Sampling and Repository
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05266222Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06029933Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 16-Ado-2026 · NCT04712539The Effects of Endotracheal Suctioning on Pain and Serum Markers
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT06692400A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 65 hanga 85 · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT07464314Flu Infection at UPHS
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT06807840First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT07169318A Study to Learn About mRNA Vaccines Against Influenza in Adults
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT07431853Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
Namoota walitti qabaa jiraSadarkaa 4Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 49 · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT06841913H5N1 Milk Detection Study
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06850298The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
6 Months – 99 Years · Saalaa hunda · Haaromfame 08-Elb-2026 · NCT05832307MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 06-Elb-2026 · NCT05735717Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.